Cas no 29823-25-4 (Methyl Octadecanoate-d35)
Methyl Octadecanoate-d35 Chemical and Physical Properties
Names and Identifiers
-
- Octadecanoic-d35acid, methyl ester (9CI)
- Methyl octadecanoate-d35
- (Z)-pentatriacont-17-ene
- 17-pentatriacontene
- deuterated methyl stearate
- Methyl octadecanoate-d351000μg
- Methyl-perdeuterio-octadecanoat
- Pentatriacont-17-en
- pentatriaconta-C-deuterio-octadecanoic acid methyl ester
- Pentatriacontan-17-ene
- Octadecanoic-d35 acid, methyl ester
- HY-B1934S1
- CS-0438012
- 29823-25-4
- DTXSID801292197
- Octadecanoic-d35acid,methyl ester(9ci)
- D97938
- Methyl stearate-d35
- methyl 2, 2, 3, 3, 4, 4, 5, 5, 6, 6, 7, 7, 8, 8, 9, 9, 10, 10, 11, 11, 12, 12, 13, 13, 14, 14, 15, 15, 16, 16, 17, 17, 18, 18, 18-pentatriacontadeuteriooctadecanoate
- Methyl Octadecanoate-d35
-
- Inchi: 1S/C19H38O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-2/h3-18H2,1-2H3/i1D3,3D2,4D2,5D2,6D2,7D2,8D2,9D2,10D2,11D2,12D2,13D2,14D2,15D2,16D2,17D2,18D2
- InChI Key: HPEUJPJOZXNMSJ-JRUFZKPWSA-N
- SMILES: O(C)C(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O
Computed Properties
- Exact Mass: 333.506866559g/mol
- Monoisotopic Mass: 333.506866559g/mol
- Isotope Atom Count: 35
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 21
- Rotatable Bond Count: 17
- Complexity: 214
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 9
- Topological Polar Surface Area: 26.3?2
Methyl Octadecanoate-d35 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M326691-2.5mg |
Methyl Octadecanoate-d35 |
29823-25-4 | 2.5mg |
$ 64.00 | 2023-09-07 | ||
| TRC | M326691-5mg |
Methyl Octadecanoate-d35 |
29823-25-4 | 5mg |
$ 81.00 | 2023-09-07 | ||
| TRC | M326691-25mg |
Methyl Octadecanoate-d35 |
29823-25-4 | 25mg |
$115.00 | 2023-05-17 |
Methyl Octadecanoate-d35 Related Literature
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
-
Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
-
Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
Additional information on Methyl Octadecanoate-d35
Recent Advances in the Application of Methyl Octadecanoate-d35 (CAS: 29823-25-4) in Chemical and Biomedical Research
Methyl Octadecanoate-d35 (CAS: 29823-25-4), a deuterated form of methyl stearate, has recently gained significant attention in chemical and biomedical research due to its unique isotopic labeling properties. This compound serves as a critical internal standard in mass spectrometry-based lipidomics and metabolomics studies, enabling precise quantification of fatty acid metabolites. Recent studies have highlighted its utility in tracing metabolic pathways, investigating lipid metabolism disorders, and developing novel diagnostic tools for diseases such as diabetes and cardiovascular conditions.
A 2023 study published in the Journal of Lipid Research demonstrated the application of Methyl Octadecanoate-d35 in elucidating the dynamics of fatty acid β-oxidation in hepatic cells. The deuterium labeling allowed researchers to distinguish endogenous stearate from exogenous sources, providing unprecedented insights into lipid turnover rates under various metabolic conditions. This work underscores the compound's value in mechanistic studies of metabolic diseases.
In pharmaceutical development, Methyl Octadecanoate-d35 has emerged as a crucial quality control standard for lipid-based drug formulations. A recent industry report from the European Journal of Pharmaceutical Sciences detailed its use in validating the stability testing protocols for omega-3 fatty acid supplements, where its consistent fragmentation pattern in GC-MS analysis proved invaluable for method validation and regulatory compliance.
Cutting-edge research presented at the 2024 American Chemical Society meeting revealed novel synthetic routes for Methyl Octadecanoate-d35 that significantly improve isotopic purity (>99.5% deuterium incorporation) while reducing production costs. These advancements are expected to broaden accessibility for research institutions and accelerate studies in lipid metabolism and biomarker discovery.
The compound's application has expanded into clinical research, with a recent multicenter study employing Methyl Octadecanoate-d35 as a tracer in stable isotope breath tests for assessing pancreatic exocrine function. This innovative diagnostic approach, published in Clinical Chemistry, demonstrated superior accuracy compared to conventional methods, potentially revolutionizing the diagnosis of pancreatic disorders.
Looking forward, the unique properties of Methyl Octadecanoate-d35 position it as a key tool in emerging areas such as single-cell lipidomics and spatial metabolomics. Ongoing research aims to leverage its stable isotopic signature to map lipid distributions in tissues at cellular resolution, opening new frontiers in our understanding of lipid-related disease mechanisms and therapeutic interventions.
29823-25-4 (Methyl Octadecanoate-d35) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)